Toronto Dominion Bank Has $45.60 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)
Toronto Dominion Bank decreased its stake in Colgate-Palmolive (NYSE:CL) by 21.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 622,336 shares of the company’s stock after selling 170,955 shares during the quarter. Toronto Dominion Bank’s holdings in Colgate-Palmolive were worth $45,600,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Massachusetts Financial Services Co. MA increased its stake in shares of Colgate-Palmolive by 5.0% in the first quarter. Massachusetts Financial Services Co. MA now owns 35,125,475 shares of the company’s stock worth $2,330,928,000 after acquiring an additional 1,686,475 shares during the last quarter. Wellington Management Group LLP grew its stake in Colgate-Palmolive by 3.4% in the first quarter. Wellington Management Group LLP now owns 26,602,342 shares of the company’s stock valued at $1,765,333,000 after purchasing an additional 863,629 shares in the last quarter. Geode Capital Management LLC grew its stake in Colgate-Palmolive by 2.8% in the first quarter. Geode Capital Management LLC now owns 14,186,086 shares of the company’s stock valued at $940,015,000 after purchasing an additional 385,666 shares in the last quarter. Capital World Investors acquired a new position in Colgate-Palmolive in the 1st quarter worth about $829,740,000. Finally, Invesco Ltd. lifted its holdings in shares of Colgate-Palmolive by 11.8% during the 1st quarter. Invesco Ltd. now owns 8,491,664 shares of the company’s stock valued at $563,509,000 after buying an additional 894,945 shares during the last quarter. 76.74% of the stock is owned by institutional investors.
Shares of Colgate-Palmolive stock traded down $0.03 during trading on Wednesday, reaching $76.91. The company’s stock had a trading volume of 185,272 shares, compared to its average volume of 3,061,158. Colgate-Palmolive has a one year low of $58.49 and a one year high of $80.10. The company has a debt-to-equity ratio of 9.40, a quick ratio of 0.59 and a current ratio of 0.92. The firm has a market cap of $65.97 billion, a price-to-earnings ratio of 25.83, a price-to-earnings-growth ratio of 4.43 and a beta of 0.58. The business’s fifty day moving average price is $77.25 and its 200-day moving average price is $72.38.
The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 2.29%. The ex-dividend date of this dividend is Thursday, October 22nd. Colgate-Palmolive’s payout ratio is currently 62.19%.
In related news, SVP John J. Huston sold 84,905 shares of the firm’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $77.18, for a total value of $6,552,967.90. Following the completion of the transaction, the senior vice president now directly owns 82,988 shares of the company’s stock, valued at $6,405,013.84. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 41,386 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $75.80, for a total transaction of $3,137,058.80. Following the sale, the insider now owns 76,228 shares in the company, valued at approximately $5,778,082.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 256,206 shares of company stock valued at $19,617,943. Insiders own 0.78% of the company’s stock.
Several equities analysts recently weighed in on the stock. Deutsche Bank raised their price objective on shares of Colgate-Palmolive from $75.00 to $78.00 and gave the company a “hold” rating in a research report on Monday, August 3rd. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, July 31st. Royal Bank of Canada reiterated a “buy” rating and issued a $88.00 price objective on shares of Colgate-Palmolive in a report on Thursday, July 30th. Finally, Morgan Stanley raised their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company’s stock. Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $75.33.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Story: What is a conference call?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.